Bronchogen

Bronchogen is a synthetic tetrapeptide (Ala-Glu-Asp-Leu) developed by Russian researcher Vladimir Khavinson as part of his bioregulator program. The Khavinson bioregulators are short peptides extracted from or modeled after specific organ tissues, and Bronchogen corresponds to bronchial epithelium. It is studied for its effects on respiratory tract tissue and is sold strictly for laboratory research.

Khavinson's lab in St. Petersburg spent decades isolating tiny peptides from animal organs, then synthesizing the active fragments. The idea is that each peptide acts as a tissue-specific 'regulator' — Bronchogen for lungs, Cardiogen for heart, Pinealon for brain, and so on. Bronchogen is studied as a respiratory-tract peptide that influences gene expression in bronchial epithelial cells, the lining of your airways. It is one of the lesser-known peptides in the West but has a substantial Russian-language research literature.

Short bioregulator peptides like Bronchogen are proposed to enter cells, reach the nucleus, and modulate transcription of tissue-specific genes — essentially acting as small transcriptional signals. In animal and cell-culture work, Bronchogen has been associated with normalized respiratory epithelium structure and reduced markers of chronic airway inflammation. The mechanistic detail is less established than for larger, better-characterized peptides.

• •Chronic obstructive pulmonary disease (COPD) models
• •Bronchial epithelium regeneration
• •Age-related respiratory function decline
• •Tissue-specific gene expression modulation
• •Khavinson bioregulator family comparative studies

Bronchogen is niche even by research-peptide standards. It shows up mostly on longevity forums alongside Epitalon and other Khavinson peptides, with occasional threads from users with chronic respiratory issues experimenting based on Russian literature. There is far less English-language clinical data than for the more popular peptides.

“A tiny tissue-specific switch for the lungs.”

Bronchogen is commonly discussed alongside Epitalon, Cortagen, and other Khavinson bioregulators in longevity 'organ-system' protocols. The premise — entirely informal — is that each bioregulator targets its corresponding tissue.

Bronchogen is a tetrapeptide from the Khavinson bioregulator family studied for bronchial epithelium repair and respiratory health. It is part of a tissue-specific peptide design philosophy and is sold for laboratory research only.